Citius Oncology
Price & Volume
Stats
See more52W Range | $0.49-$1.83 |
Market Cap | $58.1M |
Shares Short | 227,455 |
Financials
See moreRevenue (12 Mos) | $7.1M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $5.3M |
Diluted EPS | -$0.44 |
News
See moreYahoo Finance • 10 days ago
Citius Oncology Reports Continued Institutional Demand and 120% Growth in Shipments of LYMPHIR® Units to U.S. Wholesalers During the Fiscal Fourth Quarter of 2026
Yahoo Finance • 3 months ago
Citius Oncology shares tumble as Q3 revenue misses forecasts despite LYMPHIR launch momentum
Yahoo Finance • 6 months ago
Citius raises $36.5m for Lymphir commercialisation
Yahoo Finance • 11 months ago
Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations
About
CEO | Mr. Leonard L. Mazur |
CFO | Mr. Jaime Bartushak |
Address | 11 Commerce Drive, Cranford, NJ, United States, 07016 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 0 |